What diseases does Teriflunomide treat?

Teriflunomide blocks the action of specific enzymes in the body that prevent these lymphocytes from dividing. This is thought to reduce the number of lymphocytes, interfering with their ability to mount a disease response and neurological damage, ultimately leading to relapse. In clinical trials, teriflunomide has been shown to reduce the frequency of multiple sclerosis (MS) relapses and slow the progression of physical disability.

Teriflunomide is available as an oral tablet. The usual dose of this medicine is one 14 mg tablet per day, which can be taken with or without food. Teriflunomide helps most people with multiple sclerosis, but it may have side effects in some people. All medicines have side effects. The most common side effects of teriflunomide include nausea, elevated liver enzymes, diarrhea, and hair thinning, with less common effects including increased blood pressure and skin disorders. In rare cases, some people may develop liver or blood problems, gastrointestinal disorders, severe skin reactions, and allergic reactions.

The original drug Teriflunomide has been marketed in China and has entered the scope of medical insurance through medical insurance reimbursement standards. It may be limited to multiple sclerosis patients who are ineffective in conventional treatments. However, the reimbursement ratio is different in different regions, and the price after reimbursement is different. Specifications The price of 14mg*28 tablets per box is around 10,000 yuan, which is expensive. Cheaper generic drugs are also sold in other overseas countries. The pharmaceutical ingredients of generic drugs are basically the same as those of the original drugs. The price of each box of 14mg*30 tablets produced by an Indian pharmaceutical factory is around RMB 800 (the price may fluctuate due to exchange rates).